Workshop on the clinical significance of red blood cell alloantibodies organized by the Working Party on Immunohaematology of the International Society of Blood Transfusion
By: T. Peyrard
Paid access
|Feb 2020References
- Whitaker BI, Strong DM, Gandhi MJ, Petrisli E. Hemovigiliance and the Notify Library. Immunohematology 2017;33:159–64.
- Nance SJ. A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies. Immunohematology 2018;34:11–5.
- Lomas-Francis C. Clinical significance of antibodies to antigens in the International Society of Blood Transfusion collections, 700 series of low-incidence antigens, and 901 series of high-incidence antigens. Immunohematology 2018;34:39–45.
- Moghaddam M, Naghi AA. Clinical significance of antibodies to antigens in the Raph, John Milton Hagen, I, Globoside, Gill, Rh-associated glycoproteins, FORS, JR, LAN, Vel, CD59, and Augustine blood group systems. Immunohematology 2018;34:85–90.
- Lejon Crottet S. Clinical significance of antibodies to antigens in the Scianna, Dombrock, Colton, Landsteiner-Weiner, Chido/Rodgers, H, Kx, Cromer, Gerbich, Knops, Indian, and Ok blood group systems. Immunohematology 2018;34:103–8.
- Nicole TN, Grimsley SP. Clinical significance of antibodies to antigens in the ABO, MNS, P1PK, Rh, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Yt, and Xg blood group systems. Immunohematology 2019;35:95–101.
DOI: https://doi.org/10.21307/immunohematology-2020-023 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 105 - 107
Published on: Feb 16, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 T. Peyrard, published by American National Red Cross
This work is licensed under the Creative Commons License.